Gulinnaz Ercan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gulinnaz Ercan has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Morteza Akbari
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4 shared publications - Ali Adili
Department of Oncology, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publications - Rozita Tamjidifar
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publications - Shadi Ghoreishizadeh
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publications Soycan Mizrak
Department of Medical Biochemistry, Faculty of Medicine, Usak University, Usak, Turkey
3 shared publications- Faroogh Marofi
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications
Latest Publications
- Open Access
- 8 September 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1
Correction: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
- 8 September 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1
Open AccessCorrection: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
- Open Access
- 7 July 2022
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 15 (1) , 1-14
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview
Ovarian cancer (OC), a frequent malignant tumor that affects women, is one of the leading causes of cancer-related death in this group of individuals. For the treatment of ovarian cancer, systemic chemotherapy with platinum-based drugs or taxanes is the first-line option. However, drug resistance developed over time during chemotherapy medications worsens the situation. Since uncertainty exists for the mechanism of chemotherapy resistance in ovarian cancer, there is a need to investigate and overcome this problem. miRNAs are engaged in various signaling pathways that contribute to the chemotherapeutic resistance of ovarian cancer. In the current study, we have tried to shed light on the mechanisms by which microRNAs contribute to the drug resistance of ovarian cancer and the use of some microRNAs to combat this chemoresistance, leading to the worse outcome of ovarian cancer patients treated with systemic chemotherapeutics.
- 7 July 2022
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 15 (1) , 1-14
Open AccessA comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview
Ovarian cancer (OC), a frequent malignant tumor that affects women, is one of the leading causes of cancer-related death in this group of individuals. For the treatment of ovarian cancer, systemic chemotherapy with platinum-based drugs or taxanes is the first-line option. However, drug resistance developed over time during chemotherapy medications worsens the situation. Since uncertainty exists for the mechanism of chemotherapy resistance in ovarian cancer, there is a need to investigate and overcome this problem. miRNAs are engaged in various signaling pathways that contribute to the chemotherapeutic resistance of ovarian cancer. In the current study, we have tried to shed light on the mechanisms by which microRNAs contribute to the drug resistance of ovarian cancer and the use of some microRNAs to combat this chemoresistance, leading to the worse outcome of ovarian cancer patients treated with systemic chemotherapeutics.
- Open Access
- 15 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
- 15 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1
Open AccessCorrection to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
- Open Access
- 2 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-10
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Coronavirus disease (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in Wuhan, China, in late December 2019 and has become a major global concern due to severe respiratory infections and high transmission rates. Evidence suggests that the strong interaction between SARS-CoV-2 and patients' immune systems leads to various clinical symptoms of COVID-19. Although the adaptive immune responses are essential for eliminating SARS-CoV-2, the innate immune system may, in some cases, cause the infection to progress. The cytotoxic CD8+ T cells in adaptive immune responses demonstrated functional exhaustion through upregulation of exhaustion markers. In this regard, humoral immune responses play an essential role in combat SARS-CoV-2 because SARS-CoV-2 restricts antigen presentation through downregulation of MHC class I and II molecules that lead to the inhibition of T cell-mediated immune response responses. This review summarizes the exact pathogenesis of SARS-CoV-2 and the alteration of the immune response during SARS-CoV-2 infection. In addition, we’ve explained the exhaustion of the immune system during SARS-CoV-2 and the potential immunomodulation approach to overcome this phenomenon.
- 2 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-10
Open AccessA comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Coronavirus disease (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in Wuhan, China, in late December 2019 and has become a major global concern due to severe respiratory infections and high transmission rates. Evidence suggests that the strong interaction between SARS-CoV-2 and patients' immune systems leads to various clinical symptoms of COVID-19. Although the adaptive immune responses are essential for eliminating SARS-CoV-2, the innate immune system may, in some cases, cause the infection to progress. The cytotoxic CD8+ T cells in adaptive immune responses demonstrated functional exhaustion through upregulation of exhaustion markers. In this regard, humoral immune responses play an essential role in combat SARS-CoV-2 because SARS-CoV-2 restricts antigen presentation through downregulation of MHC class I and II molecules that lead to the inhibition of T cell-mediated immune response responses. This review summarizes the exact pathogenesis of SARS-CoV-2 and the alteration of the immune response during SARS-CoV-2 infection. In addition, we’ve explained the exhaustion of the immune system during SARS-CoV-2 and the potential immunomodulation approach to overcome this phenomenon.
- 10 November 2020
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 45 (4) , 1522-1527
The effect of long term nicotine exposure on endothelial function in rats
Nicotine is one of the main chemicals in the cigarettes responsible for addiction formation. Many researches investigating the effects of nicotine on coronary heart disease and atherosclerosis have been published. The robustness of endothelial cells is very important in the development of atherosclerosis. The aim of this study is to evaluate the effect of nicotine exposure on the indicators of endothelial function either by examining the vascular reactivity of aorta taken from rats exposed to nicotine during prenatal (starting by the mating period) and postnatal periods (6 weeks after delivery), or by determining the protein expression of nitric oxide synthase (NOS) enzymes, NADPH oxidase (Nox) and nitrotyrosine. Chronic nicotine exposure at 6 mg/L in drinking water produced a significant decrease in phenylephrine contractility of thoracic aortic rings compared to control and low dose exposure group (0.4 mg/L, p < 0.001). Endothelium-dependent relaxations to acetylcholine increased dose-dependently while no changes were observed in endothelium-independent relaxations to sodium nitroprusside and protein expressions in rat thoracic aorta. It has been concluded that long term nicotine exposure does not have serious effects on endothelial vasodilator response directly and does not change protein expression of NOS or Nox enzymes. However, more studies should be done for the exact mechanisms responsible for the effect of nicotine on endothelial function.
- 10 November 2020
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 45 (4) , 1522-1527
The effect of long term nicotine exposure on endothelial function in rats
Nicotine is one of the main chemicals in the cigarettes responsible for addiction formation. Many researches investigating the effects of nicotine on coronary heart disease and atherosclerosis have been published. The robustness of endothelial cells is very important in the development of atherosclerosis. The aim of this study is to evaluate the effect of nicotine exposure on the indicators of endothelial function either by examining the vascular reactivity of aorta taken from rats exposed to nicotine during prenatal (starting by the mating period) and postnatal periods (6 weeks after delivery), or by determining the protein expression of nitric oxide synthase (NOS) enzymes, NADPH oxidase (Nox) and nitrotyrosine. Chronic nicotine exposure at 6 mg/L in drinking water produced a significant decrease in phenylephrine contractility of thoracic aortic rings compared to control and low dose exposure group (0.4 mg/L, p < 0.001). Endothelium-dependent relaxations to acetylcholine increased dose-dependently while no changes were observed in endothelium-independent relaxations to sodium nitroprusside and protein expressions in rat thoracic aorta. It has been concluded that long term nicotine exposure does not have serious effects on endothelial vasodilator response directly and does not change protein expression of NOS or Nox enzymes. However, more studies should be done for the exact mechanisms responsible for the effect of nicotine on endothelial function.
- Open Access
- 6 December 2018
- Published by MDPI AG in Proceedings
- Vol. 2 (25) , 1546
The Effect of Pre-Postnatal Nicotine Exposure on Types and Levels of Plasma Sialic Acids in Rats
Nicotine, is an alkaloid compound consisting of pyridine and pyrolidine ring. Its closed formula is C10H4N2. During smoking peak plasma concentration changes from 25 to 50 ng/mL. Its half-life is 1–2 h. Nicotine is metabolized primarily in the liver and excreted by the kidneys. The plasma concentration of the nicotine metabolite cotinine is 10 times more than nicotine and its half-life is longer around 15 to 20 h. Cotinine can be found in both amniotic fluid and umbilical cord blood given that it passes across the placental barrier. Adverse effects of nicotine and its metabolites on the fetus are suggested but have not been proven by scientific explanations till now. Sialic acid (Sia) is a modified nine-carbon sugar. They are located on the last end of the glycan chains located in the glycoconjugate structures. They organize a wide range of relationships between cells and their environment such as cellular recognition, adhesion, transmission, differentiation and aging. The aim of this study is to determine the possible changes in the sialic acid levels and types in the plasma after different levels of nicotine applied to Swiss Albino rats in order to assess the effect of long-term per oral nicotine administration.
- 6 December 2018
- Published by MDPI AG in Proceedings
- Vol. 2 (25) , 1546
Open AccessThe Effect of Pre-Postnatal Nicotine Exposure on Types and Levels of Plasma Sialic Acids in Rats
Nicotine, is an alkaloid compound consisting of pyridine and pyrolidine ring. Its closed formula is C10H4N2. During smoking peak plasma concentration changes from 25 to 50 ng/mL. Its half-life is 1–2 h. Nicotine is metabolized primarily in the liver and excreted by the kidneys. The plasma concentration of the nicotine metabolite cotinine is 10 times more than nicotine and its half-life is longer around 15 to 20 h. Cotinine can be found in both amniotic fluid and umbilical cord blood given that it passes across the placental barrier. Adverse effects of nicotine and its metabolites on the fetus are suggested but have not been proven by scientific explanations till now. Sialic acid (Sia) is a modified nine-carbon sugar. They are located on the last end of the glycan chains located in the glycoconjugate structures. They organize a wide range of relationships between cells and their environment such as cellular recognition, adhesion, transmission, differentiation and aging. The aim of this study is to determine the possible changes in the sialic acid levels and types in the plasma after different levels of nicotine applied to Swiss Albino rats in order to assess the effect of long-term per oral nicotine administration.
- 16 February 2018
- Published by Springer Nature in Molecular Biology Reports
- Vol. 45 (3) , 233-244
Comparative analysis of human UCB and adipose tissue derived mesenchymal stem cells for their differentiation potential into brown and white adipocytes
The differentiation potential of umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) into brown and white adipocytes in comparison to Adipose tissue derived MSCs (AD-MSCs) were investigated in order to characterize their potency for future cell therapies. MSCs were isolated from ten UCB samples and six liposuction materials. MSCs were differentiated into white and brown adipocytes after characterization by flow cytometry. Differentiated adipocytes were stained with Oil Red O and hematoxylin/eosin. The UCP1 protein levels in brown adipocytes were investigated by immunofluoresence and western blot analysis. Cells that expressed mesenchymal stem cells markers (CD34−, CD45−, CD90+ and CD105+) were successfully isolated from UCB and adipose tissue. Oil Red O staining demonstrated that white and brown adipocytes obtained from AD-MSCs showed 85 and 61% of red pixels, while it was 3 and 1.9%, respectively for white and brown adipocytes obtained from UCB-MSCs. Fluorescence microscopy analysis showed strong uncoupling protein 1 (UCP1) signaling in brown adipocytes, especially which were obtained from AD-MSCs. Quantification of UCP1 protein amount showed 4- and 10.64-fold increase in UCP1 contents of brown adipocytes derived from UCB-MSCs and AD-MSCs, respectively in comparison to undifferentiated MSCs (P < 0.004). UCB-MSCs showed only a little differentiation tendency into adipocytes means it is not an appropriate stem cell type to be differentiated into these cell types. In contrast, high differentiation efficiency of AD-MSCs into brown and white adipocytes make it appropriate stem cell type to use in future regenerative medicine of soft tissue disorders or fighting with obesity and its related disorders.
- 16 February 2018
- Published by Springer Nature in Molecular Biology Reports
- Vol. 45 (3) , 233-244
Comparative analysis of human UCB and adipose tissue derived mesenchymal stem cells for their differentiation potential into brown and white adipocytes
The differentiation potential of umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) into brown and white adipocytes in comparison to Adipose tissue derived MSCs (AD-MSCs) were investigated in order to characterize their potency for future cell therapies. MSCs were isolated from ten UCB samples and six liposuction materials. MSCs were differentiated into white and brown adipocytes after characterization by flow cytometry. Differentiated adipocytes were stained with Oil Red O and hematoxylin/eosin. The UCP1 protein levels in brown adipocytes were investigated by immunofluoresence and western blot analysis. Cells that expressed mesenchymal stem cells markers (CD34−, CD45−, CD90+ and CD105+) were successfully isolated from UCB and adipose tissue. Oil Red O staining demonstrated that white and brown adipocytes obtained from AD-MSCs showed 85 and 61% of red pixels, while it was 3 and 1.9%, respectively for white and brown adipocytes obtained from UCB-MSCs. Fluorescence microscopy analysis showed strong uncoupling protein 1 (UCP1) signaling in brown adipocytes, especially which were obtained from AD-MSCs. Quantification of UCP1 protein amount showed 4- and 10.64-fold increase in UCP1 contents of brown adipocytes derived from UCB-MSCs and AD-MSCs, respectively in comparison to undifferentiated MSCs (P < 0.004). UCB-MSCs showed only a little differentiation tendency into adipocytes means it is not an appropriate stem cell type to be differentiated into these cell types. In contrast, high differentiation efficiency of AD-MSCs into brown and white adipocytes make it appropriate stem cell type to use in future regenerative medicine of soft tissue disorders or fighting with obesity and its related disorders.
- 1 January 2016
- Published by Elsevier in Acta Histochemica
- Vol. 118 (1) , 31-37
The role of CAPE in PI3K/AKT/mTOR activation and oxidative stress on testis torsion
- 1 January 2016
- Published by Elsevier in Acta Histochemica
- Vol. 118 (1) , 31-37
The role of CAPE in PI3K/AKT/mTOR activation and oxidative stress on testis torsion
- 1 December 2012
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 13 (4) , 237-241
The effect of long term nicotine exposure on nicotine addiction and fetal growth
To investigate the effect of nicotine exposure starting before coitus and continuing during pregnancy and lactation period on delivery rate, fetal growth and nicotine addiction in rats. Ten female Swiss Albino rats were divided into 2 groups as the nicotine group (NG) (n=5), and the control group (n=5), conceived by adding 2 male rats to each group. While the control group was given only normal drinking water, 0.4 mg/kg body weight (BW)/day nicotine was given to the NG in drinking water. After delivery, the BWs of pups were recorded weekly for 6 weeks and their drinking water preferences were assessed. Meanwhile, pups of the NG continued to receive 0.4 mg/kg/day nicotine for 12 months while the controls continued with normal drinking water. At the end of the 6(th) week, it was determined that 30 (69%) rats out of 43 in the NG and only 7 rats (20%) out of 35 in the control group preferred the nicotine added drinking water (p<0.05). No significant difference was observed between control and NGs in post-natal birth weights and BWs recorded for 6 weeks. On the contrary, a significant decrease (p< 0.05) was observed in the BWs of NG at the end of 12 months nicotine exposure. Use of maternal nicotine in pregnancy and lactation periods, even at a low dose, may be effective in nicotine addiction development although it may not affect delivery rate, and BWs of pups after delivery and during six weeks follow up in the lactation period.
- 1 December 2012
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 13 (4) , 237-241
The effect of long term nicotine exposure on nicotine addiction and fetal growth
To investigate the effect of nicotine exposure starting before coitus and continuing during pregnancy and lactation period on delivery rate, fetal growth and nicotine addiction in rats. Ten female Swiss Albino rats were divided into 2 groups as the nicotine group (NG) (n=5), and the control group (n=5), conceived by adding 2 male rats to each group. While the control group was given only normal drinking water, 0.4 mg/kg body weight (BW)/day nicotine was given to the NG in drinking water. After delivery, the BWs of pups were recorded weekly for 6 weeks and their drinking water preferences were assessed. Meanwhile, pups of the NG continued to receive 0.4 mg/kg/day nicotine for 12 months while the controls continued with normal drinking water. At the end of the 6(th) week, it was determined that 30 (69%) rats out of 43 in the NG and only 7 rats (20%) out of 35 in the control group preferred the nicotine added drinking water (p<0.05). No significant difference was observed between control and NGs in post-natal birth weights and BWs recorded for 6 weeks. On the contrary, a significant decrease (p< 0.05) was observed in the BWs of NG at the end of 12 months nicotine exposure. Use of maternal nicotine in pregnancy and lactation periods, even at a low dose, may be effective in nicotine addiction development although it may not affect delivery rate, and BWs of pups after delivery and during six weeks follow up in the lactation period.
- 7 September 2012
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 287 (2) , 281-287
The effect of long-term nicotine exposure on bone mineral density and oxidative stress in female Swiss Albino rats
To evaluate the effect of long-term low or high-dose nicotine exposure on bone mass via measuring bone mineral density (BMD) and oxidant–antioxidant status markers. Thirty-five female Swiss Albino rats weighing 70 ± 10 g were divided as the control group (n = 12), low-dose nicotine group (n = 12) and high-dose nicotine group (n = 11). While the control group was given only normal drinking water, the low-dose nicotine group had 0.4 mg/kg per day and the high-dose nicotine group, 6.0 mg/kg per day of nicotine added to their water for the period of 1 year. BMD was determined with X-ray absorptiometry of lumbar vertebra, corpus femoris, proximal and distal femur. To evaluate oxidant–antioxidant status malondialdehyde (MDA) levels, superoxide dismutase (SOD) and catalase (CAT) activities were determined. When comparing the nicotine groups and controls, neither BMD nor oxidant–antioxidant status markers showed any statistically significant difference. In comparison to the controls, 12 months of high-dose oral nicotine exposure did not have a significant effect on BMD and low-dose nicotine exposure led to a statistically insignificant increase in BMD. Contrary to common belief, the results of this study show that nicotine is not responsible for the decrease in BMD leading to osteoporosis frequently seen in smokers. However, there is a need to explore the other harmful materials in tobacco which may be responsible for the alterations seen in BMD of smokers.
- 7 September 2012
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 287 (2) , 281-287
The effect of long-term nicotine exposure on bone mineral density and oxidative stress in female Swiss Albino rats
To evaluate the effect of long-term low or high-dose nicotine exposure on bone mass via measuring bone mineral density (BMD) and oxidant–antioxidant status markers. Thirty-five female Swiss Albino rats weighing 70 ± 10 g were divided as the control group (n = 12), low-dose nicotine group (n = 12) and high-dose nicotine group (n = 11). While the control group was given only normal drinking water, the low-dose nicotine group had 0.4 mg/kg per day and the high-dose nicotine group, 6.0 mg/kg per day of nicotine added to their water for the period of 1 year. BMD was determined with X-ray absorptiometry of lumbar vertebra, corpus femoris, proximal and distal femur. To evaluate oxidant–antioxidant status malondialdehyde (MDA) levels, superoxide dismutase (SOD) and catalase (CAT) activities were determined. When comparing the nicotine groups and controls, neither BMD nor oxidant–antioxidant status markers showed any statistically significant difference. In comparison to the controls, 12 months of high-dose oral nicotine exposure did not have a significant effect on BMD and low-dose nicotine exposure led to a statistically insignificant increase in BMD. Contrary to common belief, the results of this study show that nicotine is not responsible for the decrease in BMD leading to osteoporosis frequently seen in smokers. However, there is a need to explore the other harmful materials in tobacco which may be responsible for the alterations seen in BMD of smokers.